Tezpur Study Identifies Candidate Cancer Biomarkers

Tezpur Study Identifies Candidate Cancer Biomarkers

Researchers at Tezpur University in Assam identified blood-metabolite patterns that may help distinguish gallbladder cancer cases. The pilot study, led by Dr. Pankaj Bora and Dr. Chinmayee Barua, was published electronically in the Journal of Proteome Research on 6 January 2026.

Study design and findings

The researchers compared blood samples from three groups: patients with gallbladder cancer but no gallstones, patients with both gallbladder cancer and gallstones, and people with gallstones but no cancer. Described as the first study of its kind from Northeast India, it used metabolomics and computational analysis to identify patterns that could support a blood-based diagnostic approach.

Further research needed

The findings indicate potential biomarkers, not a clinically established test. The researchers said larger studies across different geographical regions are needed before the findings can be applied in clinical practice. The journal is published by the American Chemical Society.

Important Facts for Exams

  • Metabolomics scope: Metabolomics measures small molecules such as amino acids, lipids and organic acids, complementing genomics and proteomics by capturing biochemical changes closer to phenotype.
  • Discovery-to-validation step: Untargeted metabolomic studies are discovery tools; candidate signals generally require targeted assays and independent cohorts to establish reproducibility and analytical performance.
  • Gallstone risk distinction: Gallstones increase gallbladder-cancer risk, but most people with gallstones never develop cancer; their presence alone is not a cancer diagnosis.
Originally written on January 7, 2026 and last modified on November 19, 2026.
Tags: , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *